Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy

View ORCID ProfileJuan Macías, Paz González-Moreno, Esther Sánchez-García, Ramón Morillo-Verdugo, Carmen Domínguez-Quesada, Ana Pinilla, MªMar Macho, MªVictoria Martínez, Alejandro González-Serna, Anaïs Corma, Luis M. Real, Juan A. Pineda
doi: https://doi.org/10.1101/2020.05.16.20104141
Juan Macías
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan Macías
  • For correspondence: juan.macias.sanchez@gmail.com
Paz González-Moreno
2Rheumatology Unit, Hospital Universitario Virgen Macarena. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Sánchez-García
3Internal Medicine Service, Hospital Universitario Virgen de Valme. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramón Morillo-Verdugo
4Pharmacy, Hospital Universitario Virgen de Valme. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen Domínguez-Quesada
2Rheumatology Unit, Hospital Universitario Virgen Macarena. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Pinilla
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MªMar Macho
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MªVictoria Martínez
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro González-Serna
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anaïs Corma
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis M. Real
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan A. Pineda
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Hydroxychloroquine is currently being tested as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19) in several ongoing clinical trials.

Objective To compare the incidence of COVID-19 in Spanish patients with autoimmune rheumatic diseases treated with and without hydroxychloroquine.

Methods Retrospective electronic record review, from February 27th to April 16th, of patients with autoimmune inflammatory diseases followed at two academic tertiary care hospitals in Seville, Spain. The cumulative incidence of COVID-19, confirmed or suspected, was compared between patients with and without hydroxychloroquine as part of their treatment of autoimmune inflammatory diseases.

Results Among 722 included subjects, 290 (40%) were receiving hydroxychloroquine.During the seven-week study period, five (1.7%[95% CI: 0.5%–4.0%] cases of COVID-19 were registered among patients with hydroxychloroquine and five (1.2%[0.4%2.7%])(p=0.523) in without hydroxychloroquine. COVID-19 was confirmed by PCR in one (0.3%, 95% CI 0.008-1.9%) patient with hydroxychloroquine and two(0.5%,95% CI 0.05%–1.6%) without hydroxychloroquine (p=1.0). One patient on hydroxychloroquine and two subjects without hydroxychloroquine were admitted to the hospital, none of them required to be transferred to the intensive care unit and no patient died during the episode.

Conclusions The incidence and severity of COVID-19 among patients with autoimmune rheumatic diseases with and without hydroxychloroquine was not significantly different. Hydroxychloroquine does not seem to be an appropriate therapy for post-exposure prophylaxis against COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NA

Funding Statement

Not funded

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Anonymized data could be accessed if requested

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 20, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
Juan Macías, Paz González-Moreno, Esther Sánchez-García, Ramón Morillo-Verdugo, Carmen Domínguez-Quesada, Ana Pinilla, MªMar Macho, MªVictoria Martínez, Alejandro González-Serna, Anaïs Corma, Luis M. Real, Juan A. Pineda
medRxiv 2020.05.16.20104141; doi: https://doi.org/10.1101/2020.05.16.20104141
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
Juan Macías, Paz González-Moreno, Esther Sánchez-García, Ramón Morillo-Verdugo, Carmen Domínguez-Quesada, Ana Pinilla, MªMar Macho, MªVictoria Martínez, Alejandro González-Serna, Anaïs Corma, Luis M. Real, Juan A. Pineda
medRxiv 2020.05.16.20104141; doi: https://doi.org/10.1101/2020.05.16.20104141

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1245)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (534)
  • Epidemiology (10032)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2467)
  • Geriatric Medicine (238)
  • Health Economics (480)
  • Health Informatics (1647)
  • Health Policy (754)
  • Health Systems and Quality Improvement (637)
  • Hematology (250)
  • HIV/AIDS (536)
  • Infectious Diseases (except HIV/AIDS) (11872)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2290)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1249)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (734)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4844)
  • Radiology and Imaging (843)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (652)
  • Rheumatology (286)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (227)
  • Surgery (269)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)